| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/11/2002 | EP1003490B1 Transdermal therapeutic system (tts) for administering sexual steroid hormones |
| 09/11/2002 | EP0970047B1 2-alkylidene-19-nor-vitamin d compounds |
| 09/11/2002 | EP0958287B1 Sulfamide-metalloprotease inhibitors |
| 09/11/2002 | EP0956002A4 Delivery and activation through liposome incorporation of diaminocyclohexane platinum(ii) complexes |
| 09/11/2002 | EP0944715B1 Pressure-mediated intracellular delivery of molecules or microparticles |
| 09/11/2002 | EP0944614B1 Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them |
| 09/11/2002 | EP0934309B1 New pyridyl alkane acid amides as cytostatics and immunosuppressives |
| 09/11/2002 | EP0917427B1 Teat dipping agent |
| 09/11/2002 | EP0904089B1 Sterilization of female mammals |
| 09/11/2002 | EP0893999B1 Process for producing efonidipine hydrochloride preparations |
| 09/11/2002 | EP0880363B1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 09/11/2002 | EP0876367B1 Trans apovincaminic acid ester derivatives as drugs |
| 09/11/2002 | EP0862433B1 Topical foamable pharmaceutical composition for treating skin diseases induced by oval pityrosporum |
| 09/11/2002 | EP0840603B1 Pharmaceutical composition of l-dopa ethyl ester |
| 09/11/2002 | EP0837848B1 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity |
| 09/11/2002 | EP0824348B1 Treatment of psoriasis with 11-cis-retinoic acid |
| 09/11/2002 | EP0823909B1 Novel heterocyclic chemistry |
| 09/11/2002 | EP0813529B1 Arginine analogues having nitric oxide synthase inhibitor activity |
| 09/11/2002 | EP0809493B1 A method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds |
| 09/11/2002 | EP0808161B1 Solid substances comprising valproic acid and sodium valproate |
| 09/11/2002 | EP0799206B1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists |
| 09/11/2002 | EP0797445B1 Use of bioassimilable aqueous boron compounds for the control of subviral pathogenic agents |
| 09/11/2002 | EP0785789B1 Diazepino-indoles as phosphodiesterase iv inhibitors |
| 09/11/2002 | EP0769942B1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug |
| 09/11/2002 | EP0768084B1 Cancerous metastasis inhibitor |
| 09/11/2002 | EP0763036B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 09/11/2002 | EP0762870B1 Virosome-mediated intracellular delivery of therapeutic agents |
| 09/11/2002 | EP0736009B1 N-oxides of 4-arylpiperazines and 4-arylpiperidines as antipsychotic drugs |
| 09/11/2002 | EP0731788B1 Prolyl endopeptidase inhibitors |
| 09/11/2002 | EP0699070B1 Aurintricarboxylic acid fractions and analogues with anti-angiogenic activity and methods of use |
| 09/11/2002 | EP0668860B1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses |
| 09/11/2002 | CN1368977A Unsaturated cholestane derivatives and their use for preparation of meiosis regulating medicaments |
| 09/11/2002 | CN1368975A Organosilyl compounds having nuclear hormone receptor modulating activity |
| 09/11/2002 | CN1368973A Novel xanthone compounds, their preparation and use as medicament |
| 09/11/2002 | CN1368972A Nonsteroid IL-5 inhibitor, its preparation method and medical composition containing the inhibitor |
| 09/11/2002 | CN1368970A Substituted 1,4-dihydroindeno [1,2-C] pyrazoles as inhibitors of tyrosine kinase |
| 09/11/2002 | CN1368969A Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 09/11/2002 | CN1368963A Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 09/11/2002 | CN1368962A Fluorene derivatives |
| 09/11/2002 | CN1368961A Compounds for modulation of PPAP gamma activity |
| 09/11/2002 | CN1368960A Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 09/11/2002 | CN1368958A Arylsulfonamido-substituted hydroxamic acid derivatives |
| 09/11/2002 | CN1368957A Aminobenzophenones as inhibiotors of IL-1 beta and TNF-alpha |
| 09/11/2002 | CN1368953A Aminobenzophenones as inhibitors of IL-1 bata and TNF-alpha |
| 09/11/2002 | CN1368952A 1,4-substituted 4,4-diaryl cyclohexanes |
| 09/11/2002 | CN1368950A Novel aminobenzophenones |
| 09/11/2002 | CN1368948A Crystals of sodium salt of pravastatin |
| 09/11/2002 | CN1368946A New selective retinoid agonists |
| 09/11/2002 | CN1368891A Moxilfloxacin formulation containing common salt |
| 09/11/2002 | CN1368889A Ocular tension lowering composition for topical admistration |
| 09/11/2002 | CN1368887A Mycophenolate Mofetil in association with PEG-IFN alpha |
| 09/11/2002 | CN1368884A Method for modulating FXR receptor activity |
| 09/11/2002 | CN1368883A Method for reducing serum glucose and trigluceride and inhibiting vascular formation by indolealkanoic acids |
| 09/11/2002 | CN1368882A Neuronal death inhibitors |
| 09/11/2002 | CN1368881A Use of inhibitors of renin-angiotensin systemin prevention of cardiovascular events |
| 09/11/2002 | CN1368880A Water-miscible pharmaceutical compositions of paclitaxel |
| 09/11/2002 | CN1368879A Use of (-)(3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance type 2 diabetes, hyperlipidemia and hyperuricemia |
| 09/11/2002 | CN1368878A Drug therapy of restless leg syndrome |
| 09/11/2002 | CN1368876A Compositions and methods of treatment of attention deficit disorder and attention dificit/hyperactivity disorder with methylphenidate |
| 09/11/2002 | CN1368874A Implantable active ingredient depot |
| 09/11/2002 | CN1368853A Prophylactic dietary supplement based on milk |
| 09/11/2002 | CN1368503A Safflower lyochrome rich in carthamin A, its preparing process, its preparation and its medical usage |
| 09/11/2002 | CN1368499A Dihydropyridine derivative with structure of guaiacoxypropanol amine and phenoxypropanol amine |
| 09/11/2002 | CN1368052A Nano medicine 'Gansukang' and its preparing process |
| 09/11/2002 | CN1368051A Composite medicine for treating dermatopathy |
| 09/11/2002 | CN1368050A Process for preparing VE-succinate injection |
| 09/11/2002 | CN1368048A Chemically synthetic nano medicine and its preparing process, products and usage |
| 09/11/2002 | CN1090636C Production of salt clavulanic acid |
| 09/11/2002 | CN1090634C Pro-drugs and counterparts of camptothecin, their application as medicines |
| 09/11/2002 | CN1090633C Chlorophyll alpha degraded product metal complex, its preparation method and medicament for anti-gastric ulcer |
| 09/11/2002 | CN1090632C Intermediates for preparation of duocarmycin SA and derivatives thereof, and process for production of intermdiates |
| 09/11/2002 | CN1090631C Heterocyclic compounds, preparation process thereof and medicinal composition containing same |
| 09/11/2002 | CN1090629C Novel Heterocyclic compounds |
| 09/11/2002 | CN1090628C New N-aryl piperidine compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/11/2002 | CN1090627C 2-amino-1,2-indene compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/11/2002 | CN1090620C New benzimidazole, benzoxazole and benzothiazole compounds, process for preparing them and pharmaceutical compositions containing them |
| 09/11/2002 | CN1090617C Pyrole derivatives and medicinal composition |
| 09/11/2002 | CN1090614C N-(aroyl) glycine hydroxamic acid derivatives and related compounds |
| 09/11/2002 | CN1090612C Amine derivatives of oxo-and hydroxy-substituted hydrocarbons |
| 09/11/2002 | CN1090498C Quickly-acting antalgic ointment |
| 09/11/2002 | CN1090497C Medicine for treating burn |
| 09/11/2002 | CN1090496C External-use medicine for treating superficial skin fungus disease |
| 09/11/2002 | CN1090492C Ointment for treating skin tinea |
| 09/11/2002 | CN1090484C Eye drops for curing electric ophthalimia |
| 09/11/2002 | CN1090482C Massage oil for human skin |
| 09/11/2002 | CN1090481C Estrogen/progestion-antiprogestin application its composition and medicine box |
| 09/11/2002 | CN1090480C Phenoxy piperazine derivatives for treating disorders of dopamine system |
| 09/11/2002 | CN1090479C Combination of a cholesteral biosynthesis inhibitor and a beta-lactam cholesterol absorption inhibitor |
| 09/11/2002 | CN1090478C Preparations |
| 09/11/2002 | CN1090477C Ibuprofen containing solid composition |
| 09/11/2002 | CN1090476C Sterile ophthalmological gel propn. applicable in drops and process for producing it |
| 09/10/2002 | WO2001070756A2 Lipopolysaccharides (lps) extracted from escherichia coli |
| 09/10/2002 | USRE37838 Composition for contraception |
| 09/10/2002 | US6448450 A diphenylethylene pterocarpus marsupium is provided which is administered orally to decrease blood glucose levels in rats; effective antidiabetic that can reduce abnormality of glucose metabolism in diabetes |
| 09/10/2002 | US6448429 Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates |
| 09/10/2002 | US6448406 Improved process for preparation of terfenadine carboxylic acid metabolite and carebastine derivatives; histamine h1 receptor blocking and calcium antagonists; respiratory, allergic, and cardiovascular disease states |
| 09/10/2002 | US6448399 3-cycloalkyl- or propyl-2-(3,4-dihalophenyl)-n-quinolinyl-, quinazolinyl-, or quinoxolinyl-propionamide. |
| 09/10/2002 | US6448397 Treating central nervous system diseases with modulation of 5-ht activity; adrenergic, dopaminergic, and serotonergic neurotransmitters; psychosis, paraphrenia, depression, mania, schizophrenia, anxiety, migraine headache, drug addiction |
| 09/10/2002 | US6448396 Compounds useful as neuro-protective agents |
| 09/10/2002 | US6448393 Deprotecting carboxylic acid group, dehalogenating and sulfiding with heteroaryl-thio substituted compound producing 3-thiomethylcephem compounds; chemical intermediates to antibiotics, such as cefazolin and ceftriaxone |